MD1899Z - Method for treating patients with Barrett's esophagus - Google Patents
Method for treating patients with Barrett's esophagusInfo
- Publication number
- MD1899Z MD1899Z MDS20250038A MDS20250038A MD1899Z MD 1899 Z MD1899 Z MD 1899Z MD S20250038 A MDS20250038 A MD S20250038A MD S20250038 A MDS20250038 A MD S20250038A MD 1899 Z MD1899 Z MD 1899Z
- Authority
- MD
- Moldova
- Prior art keywords
- ozonized
- ozone concentration
- dry extract
- autohemotherapy
- weeks
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to medicine, in particular to gastroenterology and therapy and can be used for treating patients with Barrett's esophagus for the purpose of preventing esophageal cancer.Summary of the invention consists in alternating every 2 days the intravenous administration of ozonized 0.9% NaCl solution and major autohemotherapy, namely 200…500 mL of 0.9% NaCl solution ozonized with an ozone-oxygen mixture, with an ozone concentration of 2…12 µg/mL, are administered, and major autohemotherapy consists of collecting 300…650 mL of venous blood from the patient, which is ozonized, with an ozone concentration of 25…40 µg/mL and transfused to the patient, for 8…10 weeks, then continuing with minor autohemotherapy, which consists of collecting 5…10 mL of venous blood, which is ozonized, with an ozone concentration of 10…20 µg/mL and administered intramuscularly to the patient, 2 times a week, for 6 weeks. At the same time, in the morning on an empty stomach, ozonized drinking water with an ozone concentration of 20 µg/mL is administered orally, 250…500 mL per procedure, once a day, daily, for 30 days, at the same time, 20…30 min before meals, daily, 10…30 mL of ozonized vegetable oil with an ozone concentration of 25 µg/mL is administered orally, for up to 90 days. Concurrently with oral administrations, intestinal insufflations are performed 2…3 times a week, 150…200 mL of ozonized gas per procedure, with an ozone concentration of 10…20 µg/mL, for 8 weeks. After completing the aforesaid procedures, rinsing of the oral cavity with 100…150 mL of ozonized drinking water, with an ozone concentration of 20 µg/mL is performed, and it is administeredper os, 15 min before meals, three times a day, one capsule containing a biologically active phytotherapeutic mixture in the following ratio of components, in wt.%: dry extract of the aboveground part of chamomile 22-25, dry extract of the aboveground part of St. John's wort 14-16, dry extract of the aboveground part of yarrow 12-16, dry extract of common licorice root 15-17 and dry extract of peppermint leaves - the rest. The vegetable oil can be olive, hemp or sesame oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20250038A MD1899Z (en) | 2025-04-29 | 2025-04-29 | Method for treating patients with Barrett's esophagus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20250038A MD1899Z (en) | 2025-04-29 | 2025-04-29 | Method for treating patients with Barrett's esophagus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1899Y MD1899Y (en) | 2025-11-30 |
| MD1899Z true MD1899Z (en) | 2026-03-31 |
Family
ID=97831554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20250038A MD1899Z (en) | 2025-04-29 | 2025-04-29 | Method for treating patients with Barrett's esophagus |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1899Z (en) |
-
2025
- 2025-04-29 MD MDS20250038A patent/MD1899Z/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MD1899Y (en) | 2025-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stewart | A history of the medicinal use of tobacco 1492–1860 | |
| JP2022136154A (en) | Composition for treating schizophrenia | |
| Thomas | The modern practice of physic | |
| MD1899Y (en) | Treatment method for patients with Barrett's esophagus | |
| RU2240131C1 (en) | Agent "artrovit" for prophylaxis and treatment of arthritis and arthrosis | |
| Perera | Rauwolfia serpentina in hypertensive vascular disease. | |
| Beasley | The Book of prescriptions | |
| Long | Effect of phenylhydrazine derivatives in the treatment of polycythemia | |
| MD1862Y (en) | Method of complex treatment of inflammatory diseases of the gastrointestinal tract | |
| MD1909Y (en) | Combined treatment method for biliary dyskinesia | |
| RU2077886C1 (en) | Method of incurable patient treatment | |
| KR100318291B1 (en) | Pharmaceutical composition with thyroid function normalization, containing extract of Tobacco grass | |
| MD1918Y (en) | Method of treating precancerous conditions of the upper gastrointestinal tract associated with Helicobacter pylori infection | |
| FR2666228A1 (en) | Composition for the treatment of excessive weight and/or of cellulite | |
| RU2113241C1 (en) | Method to treat alcoholism named "a triple defence" | |
| RU2442595C2 (en) | Herbal complex for treatment of oncological diseases and method for treatment of digestive tract diseases using the said complex | |
| MD1917Y (en) | Peripheral neuropathy treatment method | |
| MD1910Y (en) | Treatment method for facial nerve paralysis | |
| Scudder | The American Eclectic materia medica and therapeutics | |
| Keller | An exploration of anaesthesia through antiquity | |
| RU2039566C1 (en) | Method for treating inflammatory and dystrophic diseases of mucous membranes of digestive organs | |
| Landesmann | Therapy of the Clinics of the Royal and Imperial Hospital of Vienna, Austria | |
| MD1798Y (en) | Method for complex treatment of herpes zoster | |
| MD1797Z (en) | Method for complex treatment of viral hepatitis D | |
| Phillips | Materia Medica, Pharmacology and Therapeutics: Inorganic Substances |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued |